Editas Medicine, Inc. (EDIT)
2.21
+0.02
(+0.91%)
USD |
NASDAQ |
Dec 24, 16:00
Editas Medicine Cash and Short Term Investments (Annual): 269.91M for Dec. 31, 2024
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| ADMA Biologics, Inc. | 103.15M |
| Arcutis Biotherapeutics, Inc. | 228.57M |
| Daré Bioscience, Inc. | 15.70M |
| Cogent Biosciences, Inc. | 287.08M |
| Janux Therapeutics, Inc. | 1.025B |